We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
SUGAMMADEX DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)
Product name
SUGAMMADEX DEMOGEN
Date registered
Evaluation commenced
Decision date
Approval time
125 (255 working days)
Active ingredients
sugammadex sodium
Registration type
New generic medicine
Indication
Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.